RxDoctor Payments Data

Stephanie Flowers, MD

Family Medicine · Grove City, OHNPI 1982708269

Payments from drug & device makers

$3,773in general payments, 2019–2025

Across 227 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$624
  • AstraZeneca$283
  • Novo Nordisk$259
  • Pfizer$206
  • GSK$158
  • Lilly USA, LLC$154
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$3,761100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,773 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$76,212
Medicare patients
192
Services billed
889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide126$157,514
EliquisApixaban126$117,638
OzempicSemaglutide78$99,397
JardianceEmpagliflozin104$94,406
JanuviaSitagliptin Phosphate96$87,907
RybelsusSemaglutide39$45,196
OxycontinOxycodone Hcl29$39,499
FarxigaDapagliflozin Propanediol37$35,656
XareltoRivaroxaban36$29,257
TrulicityDulaglutide24$28,227
MyrbetriqMirabegron41$26,401
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$24,237
LinzessLinaclotide28$20,928
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$15,526
Lantus SolostarInsulin Glargine,hum.Rec.Anlog106$13,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$154$185,741150 claims
Novo NordiskOzempic, Rybelsus$259$144,593117 claims
PfizerEliquis, Dilantin$206$120,763138 claims
MerckJanuvia, Janumet Xr$140$94,955110 claims
Boehringer IngelheimJardiance$74$94,406104 claims
GSKTrelegy Ellipta, Breo Ellipta$158$36,59148 claims
AstraZenecaFarxiga$283$35,65637 claims
Johnson & JohnsonXarelto$64$29,25736 claims
Astellas Pharma US IncMyrbetriq$66$26,40141 claims
AbbVieLinzess, Synthroid$624$24,22990 claims
Sumitomo Pharma America, Inc.Gemtesa$38$6,31713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Grove City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →